6368:TSEOrgano Corp. Analysis

Organo Corporation is priced at ¥14,555.00, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 14.9%. RSI sits at 47.0, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at ¥12,050.00 up to resistance at ¥16,245.00.
Multiples put this in undervalued territory: 23.6 times earnings against the sector's 30.7. Analyst price targets sit 42.2% above the current price. Revenue is growing at 10.7% on a 15.5% profit margin. The 0.91% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 75.5%, a beta of 1.07 and a maximum drawdown of 34.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.